Introduction: Roxadustat, the first-in class drug for treatment of renal anemia, has demonstrated efficacy in renal anemia with microinflammation. Additional data are needed regarding the efficacy of
BackgroundEvidence regarding the efficacy or effectiveness of the disease-modifying drugs (DMDs) in the older multiple sclerosis (MS) population is scarce. This has contributed to a lack of evidence-b
Detailed characteristics of systematic reviews included in the overview of systematic reviews about ibuprofen and paracetamol for treating pain in children